Back to results
UnknownPhase 2

Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer

NCT03907800

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Ruijin Hospital

Shanghai, China

View on ClinicalTrials.gov
Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer — TrialFind